PharmaShots

JUNE 23, 2023

Gilead Receives EMA’s CHMP Positive Opinion of Trodelvy (sacituzumab govitecan) for Pre-Treated HR+/HER2- Metastatic Breast Cancer Date: June 23, 2023 | Tags: Gilead, Trodelvy, sacituzumab govitecan, HR+/HER2- Metastatic Breast Cancer, Regulatory, EMA, CHMP, Positive Opinion Sarepta Therapeutics’ Elevidys Receives the US FDA’s Accelerated (..)

FDA 40

FDA 40

PharmaShots

MARCH 17, 2023

5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted

FDA 40

FDA Labelling 40

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

PharmaShots

APRIL 28, 2023

Difficile Infection Date: Apr 27, 2023 | Tags: Seres Therapeutics, Nestlé Health Science, Vowst, C.

FDA 56

FDA 56

PharmaShots

MAY 19, 2023

Alimera Acquires Rights from EyePoint Pharmaceuticals to Commercialise Yutiq in the US Date: May 19, 2023 | Tags: Alimera, EyePoint Pharmaceuticals, Yutiq, Iluvien, chronic non-infectious uveitis, US, Pharma Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A Date: May 19, 2023 | Tags: Sobi, Efanesoctocog Alfa, (..)

Medical Schools 40

Medical Schools FDA Immunization Vaccines 40

PharmaShots

MARCH 31, 2023

PDS Biotech to Initiate P-III Trial (VERSATILE-003) of PDS0101 + Keytruda (pembrolizumab) for Head and Neck Cancer Date: Mar 31, 2023 | Tags: PDS Biotech, PDS0101, Keytruda, pembrolizumab, Head, Neck Cancer, Clinical Trial, P-III, VERSATILE-003 Trial Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular (..)

FDA 40

FDA 40

PharmaShots

MARCH 24, 2023

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

FDA 40

FDA Immunization 40

PharmaShots

FEBRUARY 10, 2023

LEO Pharma Reports P-III Trial (DELTA 2) Results of Delgocitinib for Chronic Hand Eczema Date: Feb 10, 2023 | Tags: LEO Pharma, Delgocitinib, Chronic Hand Eczema, Clinical Trial, P-III, DELTA 2 Trial GSK’s Jemperli (dostarlimab-gxly) Receives the US FDA’s Regular Approval for Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer (..)

FDA 40

FDA 40

PharmaShots

FEBRUARY 10, 2023

LEO Pharma Reports P-III Trial (DELTA 2) Results of Delgocitinib for Chronic Hand Eczema Date: Feb 10, 2023 | Tags: LEO Pharma, Delgocitinib, Chronic Hand Eczema, Clinical Trial, P-III, DELTA 2 Trial GSK’s Jemperli (dostarlimab-gxly) Receives the US FDA’s Regular Approval for Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer (..)

FDA 40

FDA 40

Pharmaceutical Technology

MAY 19, 2023

Multiple sclerosis (MS) is a primary autoimmune disease in which inflammation is a core contributor to the degeneration of the central nervous system (CNS), leading to neurological disability and affecting sensory, visual, motor, and autonomic systems. DMTs for MS have a high price tag, particularly in the US.

98

98

STAT

AUGUST 2, 2023

health care system billions annually even as it remains out of reach for many lower-income seniors most likely to suffer from dementia , KFF Health News explains. Besides the $26,500 annual price tag, treatment could cost U.S. Medicare and Medicaid patients will make up 92% of the market for the drug, called Leqembi.

Insurance Coverage 73

Insurance Coverage Insurance 73

pharmaphorum

JANUARY 24, 2022

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. However, the study also found that there was less consistency in more advanced cancers, and the authors noted the system “still needs further improvement.”

Cerner 111

Cerner 111

pharmaphorum

DECEMBER 17, 2020

Tik Tok is unlikely to spring to mind as a source of reliable information about complex issues, but scientists are using it to fly the flag for COVID-19 vaccines and other health topics. When we talk about vaccines as health professionals, people who are vehemently anti-vaccine can take it out of context for their agenda.

Vaccines 89

Vaccines Communication Immunization 89

The Checkup by Singlecare

DECEMBER 5, 2023

The #ozempic tag on TikTok has amassed over 1 billion views to date. Wegovy—which contains the same active ingredient as Ozempic (semaglutide)—is prescribed to people who are obese or overweight and have other health conditions such as high blood pressure, diabetes, or high cholesterol. Elon Musk posted his endorsement of Ozempic on X.

Insurance 105

Insurance Prescription Filling FDA Dosage 105

Pharmaceutical Technology

APRIL 13, 2023

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. million to achieve $150,000 per QALY gained from a healthcare system perspective. Based on the report’s QALY-based threshold analyses, both treatments would have to have a unit price of $1.58

FDA 59

FDA 59

The Checkup by Singlecare

JANUARY 11, 2024

Read more about treatments for skin tags , hidradenitis suppurativa , and shingles. Growths “Growths such as cysts, skin tags, and moles can also cause pain when they’re inflamed,” says Brendan Camp, MD , a dermatologist with MDCS Dermatology in New York. Armpit pain can be managed with cold compresses, rest, and sometimes medication.

Mayo Clinic 52

Mayo Clinic Vaccines Immunization 52

pharmaphorum

JANUARY 21, 2022

“Access to medicines remains one of the most challenging policy areas in every country we work with through the pan-European region,” said Natasha Muscat, Director of Country Health Policies and Systems at World Health Organization (WHO) Europe. WHO is OMI? And that’s exactly what the OMI is setting out to do. About the author.

Insurance 52

Insurance Vaccines 52

pharmaphorum

NOVEMBER 24, 2022

One issue has been the cost of the drug, with health technology assessment agency NICE in the UK and the ICER organisation in the US both concluding its price tag means it is not a cost-effective option for health systems.

Labelling 52

Labelling Hospitals 52

pharmaphorum

DECEMBER 23, 2022

In the last few years, the first generation of cell therapies has offered a powerful new way of treating blood cancers, with CAR-T technology reprogramming patients’ immune system to fight cancer. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Immunization 52

Immunization Hospitals Vaccines 52

Pharmaceutical Technology

JULY 14, 2022

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The This, believes Kahn, is where the role of healthcare systems is critical. Go-to-market strategies.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

Colors Make me Happy

AUGUST 19, 2020

For Fatima, family stability was the ultimate goal — to travel across the ocean to America was the only possibility of providing it, along with good health. Her younger children thrived in the public-school system. Unless a health issue requires immediate, prompt care, trips to the doctor are avoided. health care system.

Compounding 40

Compounding Communication 40

pharmaphorum

JUNE 2, 2022

However, Ben Hargreaves finds that the blockbuster success that certain treatments are achieving is beginning to raise questions over whether healthcare systems can afford this in the long-term. Last year , the European Commission launched an open public consultation on the revision of the legislation to identify shortcoming in the system.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization Vaccines 52

The Checkup by Singlecare

JANUARY 23, 2024

Benign skin growths Skin growths such as moles, skin tags, and seborrheic keratosis can appear as bumps on the head. An individual’s overall health condition, age, and the severity of the head bump can all influence how long a bump on the head will last. Bone spurs : Bone spurs don’t typically go away unless they’re surgically removed.

52

52

pharmaphorum

NOVEMBER 16, 2022

While this is of tremendous benefit to patients, it provides a headache to the pharma industry and to healthcare systems. The UK’s NICE, the cost-effectiveness body for the country, immediately ruled that such pricing was beyond what the healthcare system could afford. However, with a price tag of €1.58 At more than $2.1

130

130

PharmaShots

MARCH 9, 2023

In addition to serving as Associate Editor-in-Chief of the IEEE Open Access Journal of Circuits and Systems, she has been an Associate Editor of IEEE Transactions on Biomedical Circuits and Systems since 2008. Present company and time period: Tivic Health (6 yrs. LinkedIn Total experience: 26 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

pharmaphorum

MAY 24, 2021

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. This results in inefficiencies including additional, duplicative or derivative content needing to be created from scratch due to the lack of a modular content eco-system.

Communication 89

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 89

PharmaShots

MARCH 10, 2023

Vertex Receives the US FDA’s IND Clearance of VX-264 for the Treatment of Type 1 Diabetes Date: Mar 10, 2023 | Tags: Vertex, VX-264, Type 1 Diabetes, Regulatory, US, FDA, IND Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies Date: Mar 10, 2023 | Tags: Alnylam, Medison Pharma, RNAi Therapies, Onpattro, patisiran, (..)

FDA 40

FDA Vaccines 40

The Spirit Pharmacist

DECEMBER 2, 2021

However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies. Back in 2013 I was completing my field study during the Master in Public Health curriculum. What can be done? I believe the answer resides in communities.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Coverage Insurance Patient Care 52

European Pharmaceutical Review

MAY 11, 2023

3 The one-time gene therapy received final draft guidance from the National Institute for Health and Care Excellence (NICE) on 16 March 2023. Transformative treatments have exposed and tested the limitations of our value assessment and reimbursement systems. 1 This is assuming a $1M price tag for all gene therapies.

FDA 70

FDA 70

pharmaphorum

AUGUST 26, 2022

BioMarin will no doubt have an eye on the earlier experience of bluebird bio, which secured EU approval for rare disease gene therapy Zynteglo (betibeglogene autotemcel) in 2019 for beta thalassaemia with a price tag of around €1.6 million spread over five years.

FDA 111

FDA 111

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. billion and $6.7 People simply can’t afford them. But there is a silver lining.

Vaccines 90

Vaccines 90

The Checkup by Singlecare

AUGUST 30, 2023

Some health insurance and Medicare Part D drug plans provide coverage for Jublia medication, but many do not. Without health insurance coverage, a single applicator bottle containing 4 mL of Jublia 10% solution costs about $960 at the full cash price. Is Jublia covered by insurance? How much does Jublia cost without insurance?

Insurance 52

Insurance Insurance Coverage FDA 52

Pharmaceutical Technology

JANUARY 27, 2023

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”. The disorder has a reported annual incidence between 1.5 cases per million in Europe.

Documentation 52

Documentation Immunization Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 4, 2022

A key part of this initiative was the establishment of the Cancer Moonshot Biobank, which will ask cancer patients to donate biospecimens and associated health information to aid research. Building a bank. Medidata has provided its Patient Cloud and Rave solutions to the Biobank, which includes eConsent and Rave EDC (electronic data capture).

Documentation 102

Documentation Data Entry HIPAA Insurance 102

The Checkup by Singlecare

JANUARY 19, 2023

Keeping blood sugar in a target range, or normal range, is important for overall health, as well as for preventing long-term health complications. Untreated high blood sugar, especially over time, may result in long-term health complications such as problems with the heart, nerves, kidneys, eyes, and feet.

Immunization 105

Immunization Hospitals Communication 105

Viseven

FEBRUARY 6, 2023

It helps to increase content marketing production capacities and offers new solutions for marketing operations, valuable data collection, and, further, advanced customer experiences you can implement (like electronic health records with patients’ direct access).

Communication 75

Communication 75